Sandeep Chidambar Kulkarni - 21 Jan 2026 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role: Chief Executive Officer, Director
Signature: /s/ Kim Davis, Attorney-in-Fact
Issuer symbol: ZURA
Transactions as of: 21 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 23 Jan 2026, 17:56:36 UTC
Previous filing: 28 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kulkarni Sandeep Chidambar	Chief Executive Officer, Director	C/O ZURA BIO LIMITED, 1489 W. WARM SPRINGS RD. #110, HENDERSON	/s/ Kim Davis, Attorney-in-Fact	23 Jan 2026	0001945691

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZURA	Employee Share Option (Right to Buy)	Award	$0	+2,934,107		$0.000000	2,934,107	21 Jan 2026	Class A Ordinary Shares	2,934,107	$6.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One fourth (1/4th) of the shares subject to the option award shall vest on January 21, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.